Trials / Completed
CompletedNCT06005506
National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.
'sPATIALS3' - National Multicenter Randomized Controlled Interventional Study, Comparing an Active Symbiotic and a Passive Symbiotic Aimed at Evaluating the Effect on the Intestinal Microbiota and on the State of Health and Well-being of Various Types of Chronically Frail Patients United by Alterations of Intestinal Function.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Institute of Biomedical Technologies-National Research Council, Italy · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the study will be to understand whether a supplementation of the diet with an active symbiotic, i.e. characterized by a mix of probiotics and a specially selected fiber with prebiotic activity combined with a vegetable extract with beneficial activities on carbohydrate and lipid metabolism, can reduce the relative inflammatory potential and improve absorption, intestinal motility and bowel habit of patients with various pathological conditions, such as ALS, ADHD and bronchial asthma.
Detailed description
Clinical survey conducted for research and study purposes, multicenter, focusing on ALS patients, elderly patients with chronic diseases, and pediatric patients with neurodevelopmental disorders. For each of the diseases treated, patients will be randomized into the two treatment arms (Study Group, GS; Control Group, GC) according to a block randomization, with a block size of 4 and an allocation ratio of 1:1. The randomization will be double-blind. * Study Group or GS: These subjects will be given an active symbiotic preparation consisting of two sticks of 1500mg each and of different colors. * Control group or GC:These subjects will be given a passive symbiotic preparation again consisting of two sticks of 1500mg each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Prebiotic fiber | Moradyn active prebiotic fiber product |
| DIETARY_SUPPLEMENT | Dietary fiber | Fibregum non-active fiber product |
| DIETARY_SUPPLEMENT | Probiotic | Defense Plus probiotic complex |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-10-31
- Completion
- 2023-03-31
- First posted
- 2023-08-22
- Last updated
- 2023-08-22
Locations
4 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06005506. Inclusion in this directory is not an endorsement.